4d pharma (NASDAQ: LBPS)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of 4d pharma (NASDAQ: LBPS) through any online brokerage.
The latest price target for 4d pharma (NASDAQ: LBPS) was reported by Chardan Capital on Monday, June 27, 2022. The analyst firm set a price target for 0.00 expecting LBPS to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
The stock price for 4d pharma (NASDAQ: LBPS) is $1.65 last updated June 24, 2022, 1:38 PM UTC.
There are no upcoming dividends for 4d pharma.
4d pharma’s H1 earnings are confirmed for Friday, September 30, 2022.
There is no upcoming split for 4d pharma.
4d pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.